These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9864827)

  • 41. [Evaluation of diagnostic efficiency of the recombinant protein modeling immunodominant epitope V3 of envelope gp120 for immunoenzyme detection for HIV-1 infection antibodies].
    Riabinina SA; Baranova EN; Sharipova IN; Susekina MI; Puzyrev VF; Obriadina AP; Burkov AN; Ulanova TI
    Mol Gen Mikrobiol Virusol; 2007; (3):33-6. PubMed ID: 17886471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fine analysis of immunoreactivity of V3 peptides: antibodies specific for V3 domain of laboratory HIV type 1 strains recognize multiple V3 sequences synthesized from field HIV type 1 isolates.
    Boudet F; Lasarte JJ; Sarobe P; Borras-Cuesta F; Theze J
    AIDS Res Hum Retroviruses; 1996 Dec; 12(18):1671-9. PubMed ID: 8959242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The molecular epidemiology of HIV-1 in Belarus in (1996-2004): a predominance of subtype A variants and circulation of subtype B variants].
    Lukashov VV; Lazovskaia NV; Karamov EV; Adema KW; Gasich EL; Baan E; Titov LP; Goudsmit J; Eremin VF
    Vopr Virusol; 2006; 51(6):22-6. PubMed ID: 17214078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seroreactivity of analogous antigenic epitopes in glycoprotein 120 expressed in HIV-1 subtypes A, B, C, and D.
    Pestano GA; Hosford KS; Spira AI; Riley J; Xie JM; Sewankambo N; Brown L; Ho DD; Boto WM
    AIDS Res Hum Retroviruses; 1995 May; 11(5):589-96. PubMed ID: 7576915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An HIV type 1 subtype A outbreak among injecting drug users in Latvia.
    Ferdats A; Konicheva V; Dievberna I; Lilja E; Albert J
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1487-90. PubMed ID: 10555112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The molecular epidemiological characteristics of the HIV-1 variants circulating among injection drug addicts on the territory of the CIS Nations].
    Karamov EV; Shchelkanov MIu; Iudin AN; Gorbacheva AP; Burunova VV; Slavskiĭ AA; Lukashov VV; Iaroslavtseva NG
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (1):39-41. PubMed ID: 10096198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Silent mutation in the V3 region characteristic of HIV type 1 env subtype B strains from injecting drug users in the former Soviet Union.
    Bobkov AF; Lukashov VV; Goudsmit J; Weber JN
    AIDS Res Hum Retroviruses; 2000 Feb; 16(3):291-4. PubMed ID: 10710217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neutralization of HIV-1 subtypes: implications for vaccine formulations.
    Smith TL; van Rensburg EJ; Engelbrecht S
    J Med Virol; 1998 Nov; 56(3):264-8. PubMed ID: 9783696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides.
    Vogel T; Kurth R; Norley S
    J Immunol; 1994 Aug; 153(4):1895-904. PubMed ID: 7519220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The reactivities of HIV-1+ human sera with solid-phase V3 loop peptides can be poor predictors of their reactivities with V3 loops on native gp120 molecules.
    Moore JP
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):209-19. PubMed ID: 8471311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV type 1 V3 domain serotyping and genotyping in Gauteng, Mpumalanga, KwaZulu-Natal, and Western Cape Provinces of South Africa.
    Engelbrecht S; Smith TL; Kasper P; Faatz E; Zeier M; Moodley D; Clay CG; van Rensburg EJ
    AIDS Res Hum Retroviruses; 1999 Mar; 15(4):325-8. PubMed ID: 10082115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 clades.
    Gorny MK; Mascola JR; Israel ZR; VanCott TC; Williams C; Balfe P; Hioe C; Brodine S; Burda S; Zolla-Pazner S
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):213-21. PubMed ID: 9491911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.
    Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR
    J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Phenotypic characteristics of HIV isolates, isolated in the Belarus Republic].
    Eremin VF
    Vopr Virusol; 1998; 43(3):113-7. PubMed ID: 9702808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotyping and genotyping of HIV-1 infection in residents of Khayelitsha, Cape Town, South Africa.
    Jacobs GB; de Beer C; Fincham JE; Adams V; Dhansay MA; van Rensburg EJ; Engelbrecht S
    J Med Virol; 2006 Dec; 78(12):1529-36. PubMed ID: 17063507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human immunodeficiency virus type 1 subtypes among Malaysian intravenous drug users.
    Saraswathy TS; Ng KP; Sinniah M
    Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):283-6. PubMed ID: 11127327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High antigenic cross-reactivity of the V3 consensus sequences of HIV-1 gp120.
    Baillou A; Brand D; Denis F; M'Boup S; Chout R; Goudeau A; Barin F
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1209-15. PubMed ID: 7511395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequent and early HIV-1MN neutralizing capacity in sera from Dutch HIV-1 seroconverters is related to antibody reactivity to peptides from the gp120 V3 domain.
    Zwart G; Back NK; Ramautarsing C; Valk M; van der Hoek L; Goudsmit J
    AIDS Res Hum Retroviruses; 1994 Mar; 10(3):245-51. PubMed ID: 8018385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High specificity of V3 serotyping among human immunodeficiency virus type-1 subtype C infected patients with varying disease status and viral phenotype.
    Walker PR; Cilliers T; Choge IA; Taylor N; Cohen SS; Morris L
    J Med Virol; 2006 Oct; 78(10):1262-8. PubMed ID: 16927278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.